rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.14412/1995-4484-2017-566-571rsp-2441Research ArticleОБЗОРREVIEWСистемный остеопороз и псориатический артрит: современные представления о состоянии проблемыSYSTEMIC OSTEOPOROSIS AND PSORIATIC ARTHRITIS: CURRENT UNDERSTANDING OF THE PROBLEMДобровольскаяО. В.DobrovolskayaO. V.

115522 Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

olgavdobr@mail.ruТоропцоваН. В.ToroptsovaN. V.

115522 Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

ЛогиноваЕ. Ю.LoginovaE. Yu.

115522 Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

КоротаеваТ. В.KorotaevaT. V.

115522 Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian Federation201727102017555566571Copyright © Добровольская О.В., Торопцова Н.В., Логинова Е.Ю., Коротаева Т.В., 20172017Добровольская О.В., Торопцова Н.В., Логинова Е.Ю., Коротаева Т.В.Dobrovolskaya O.V., Toroptsova N.V., Loginova E.Y., Korotaeva T.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/2441

Обзор посвящен проблеме генерализованного остеопороза (ОП) при псориатическом артрите (ПсА). Поиск работ за последние 15 лет проводился в системе Medline по ключевым словам: «псориатический артрит» (psoriatic artritis), «минеральная плотность кости» (bone mineral density), «остеопороз» (osteoporosis) и «переломы, связанные с остеопорозом» (fragility fractures, low-energy fractures, osteoporotic fractures). В статью включены данные исследований по изучению частоты ОП и переломов, факторов риска ОП и влияния лекарственной терапии на состояние костной ткани у больных ПсА.

The review deals with the problem of generalized osteoporosis (OP) in psoriatic arthritis (PsA). Works published in the past 15 years were sought in the Medline using the keywords «psoriatic arthritis», «osteoporosis», and «osteoporosisassociated fractures» (fragility fractures, low-energy fractures, and osteoporotic fractures). The paper includes the data of studies on the frequency of OP and fractures, the risk factors of OP, and the impact of drug therapy on bone status in patients with PsA.

псориатический артритминеральная плотность костиостеопорозостеопоротические переломыpsoriatic arthritisbone mineral densityosteoporosisosteoporotic fracturesReferencesКоротаева ТВ. Псориатический артрит: классификация, клиническая картина, диагностика, лечение. Научно- практическая ревматология. 2014;52(6):650-9 [Korotaeva TV. Psoriatic arthritis: Classification, clinical presentation, diagnosis, treatment. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(6):650-9 (In Russ.)]. doi: 10.14412/1995-4484-2014-650-659Коротаева ТВ. Псориатический артрит: классификация, клиническая картина, диагностика, лечение. Научно- практическая ревматология. 2014;52(6):650-9 [Korotaeva TV. Psoriatic arthritis: Classification, clinical presentation, diagnosis, treatment. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(6):650-9 (In Russ.)]. doi: 10.14412/1995-4484-2014-650-659Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii14-7. doi: 10.1136/ard.2004.032482Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii14-7. doi: 10.1136/ard.2004.032482Olivieri I, Padula A, D'Angelo S, Cutro MS. Psoriatic arthritis sine psoriasis. J Rheumatol. 2009;Suppl 83:28-9. doi: 10.3899/jrheum.090218Olivieri I, Padula A, D'Angelo S, Cutro MS. Psoriatic arthritis sine psoriasis. J Rheumatol. 2009;Suppl 83:28-9. doi: 10.3899/jrheum.090218NIH Consensus Development Conference on Osteoporosis: Prevention, Diagnosis and Therapy. JAMA. 2000;287:785-95.NIH Consensus Development Conference on Osteoporosis: Prevention, Diagnosis and Therapy. JAMA. 2000;287:785-95.Dheda K, Cassim B, Patel N, Mody GM. A comparison of bone mineral density in Indians with psoriatic polyarthritis and healthy Indian volunteers. Clin Rheumatol. 2004;23:89. doi: 10.1007/s10067-003-0818-yDheda K, Cassim B, Patel N, Mody GM. A comparison of bone mineral density in Indians with psoriatic polyarthritis and healthy Indian volunteers. Clin Rheumatol. 2004;23:89. doi: 10.1007/s10067-003-0818-yBorman P, Babaoglu S, Gur G, et al. Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin Rheumatol. 2008;27:443-7. doi: 10.1007/s10067-007-0725-8Borman P, Babaoglu S, Gur G, et al. Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin Rheumatol. 2008;27:443-7. doi: 10.1007/s10067-007-0725-8D'Epiro S, Marocco C, Salvi M, et al. Psoriasis and bone mineral density: implications for long-term patients. J Dermatol. 2014 Sep;41(9):783-7. doi: 10.1111/1346-8138.12546D'Epiro S, Marocco C, Salvi M, et al. Psoriasis and bone mineral density: implications for long-term patients. J Dermatol. 2014 Sep;41(9):783-7. doi: 10.1111/1346-8138.12546Hofbauer LC, Schoppet M, Christ M. Tumour necrosis factorrelated apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis. Rheumatology. 2006;45:1218- 22. doi: 10.1093/rheumatology/kel108Hofbauer LC, Schoppet M, Christ M. Tumour necrosis factorrelated apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis. Rheumatology. 2006;45:1218- 22. doi: 10.1093/rheumatology/kel108Busquets N, Vaquero CG, Moreno JR, et al. Bone mineral density status and frequency of osteoporosis and clinical fractures in 155 patients with psoriatic arthritis followed in a university hospital. Reumatol Clin. 2014 Mar-Apr;10(2):89-93. doi: 10.1016/j.reuma.2013.07.006Busquets N, Vaquero CG, Moreno JR, et al. Bone mineral density status and frequency of osteoporosis and clinical fractures in 155 patients with psoriatic arthritis followed in a university hospital. Reumatol Clin. 2014 Mar-Apr;10(2):89-93. doi: 10.1016/j.reuma.2013.07.006Teichmann J, Voglau MJ, Lange U. Antibodies to human tissue transglutaminase and alterations of vitamin D metabolism in ankylosing spondylitis and psoriatic arthritis. Rheumatol Int. 2010;30:1559-63. doi: 10.1007/s00296-009-1186-yTeichmann J, Voglau MJ, Lange U. Antibodies to human tissue transglutaminase and alterations of vitamin D metabolism in ankylosing spondylitis and psoriatic arthritis. Rheumatol Int. 2010;30:1559-63. doi: 10.1007/s00296-009-1186-yGrazio S, Cvijetic S, Vlak T, et al. Osteoporosis in psoriatic arthritis: is there any? Wien Klin Wochenschr. 2011 Dec;123(23-24):743-50. doi: 10.1007/s00508-011-0095-8Grazio S, Cvijetic S, Vlak T, et al. Osteoporosis in psoriatic arthritis: is there any? Wien Klin Wochenschr. 2011 Dec;123(23-24):743-50. doi: 10.1007/s00508-011-0095-8Aldei A, Chandran S, Li S, et al. Osteoporosis in Psoriatic Arthritis [abstract]. Arthritis Rheum. 2015;67 Suppl 10.Aldei A, Chandran S, Li S, et al. Osteoporosis in Psoriatic Arthritis [abstract]. Arthritis Rheum. 2015;67 Suppl 10.Kincse G, Bhattoa PH, Heredi E, et al. Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. J Dermatol. 2015 Jul;42(7):679-84. doi: 10.1111/1346-8138.12876Kincse G, Bhattoa PH, Heredi E, et al. Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. J Dermatol. 2015 Jul;42(7):679-84. doi: 10.1111/1346-8138.12876Frediani B, Allegri A, Falsetti P, et al. Bone mineral density in patients with psoriatic arthritis. J Rheumatol. 2001;28:138-43.Frediani B, Allegri A, Falsetti P, et al. Bone mineral density in patients with psoriatic arthritis. J Rheumatol. 2001;28:138-43.Ovcharov P, Loginova E, Korotaeva T, et al. Bone mineral density in early psoriatic arthritis. Clin Exp Rheumatol. 2014;32(4 Suppl 83):98, P-309.Ovcharov P, Loginova E, Korotaeva T, et al. Bone mineral density in early psoriatic arthritis. Clin Exp Rheumatol. 2014;32(4 Suppl 83):98, P-309.Гладкова ЕН, Кожемякина ЕВ, Евстигнеева ЛП и др. Остеопороз и ассоциированные с ним переломы у пациентов старшего возраста с воспалительными ревматическими заболеваниями. Остеопороз и остеопатии. 2015;(2):9-14 [Gladkova EN, Kozhemyakina EV, Evstigneeva LP, et al. Osteoporosis and associated fractures in older patients with inflammatory rheumatic diseases. Osteoporoz i Osteopatii. 2015;(2):9-14 (In Russ.)].Гладкова ЕН, Кожемякина ЕВ, Евстигнеева ЛП и др. Остеопороз и ассоциированные с ним переломы у пациентов старшего возраста с воспалительными ревматическими заболеваниями. Остеопороз и остеопатии. 2015;(2):9-14 [Gladkova EN, Kozhemyakina EV, Evstigneeva LP, et al. Osteoporosis and associated fractures in older patients with inflammatory rheumatic diseases. Osteoporoz i Osteopatii. 2015;(2):9-14 (In Russ.)].Chandran S, Aldei A, Johnson SR, et al. Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review. Semin Arthritis Rheum. 2016 Oct;46(2):174-82. doi: 10.1016/j.semarthrit.2016.05.005Chandran S, Aldei A, Johnson SR, et al. Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review. Semin Arthritis Rheum. 2016 Oct;46(2):174-82. doi: 10.1016/j.semarthrit.2016.05.005Van der Weijden MA, van der Horst-Bruinsma IE, van Denderen JC, et al. High frequency of vertebral fractures in early spondylarthropathies. Osteoporos Int. 2012;23:1683-90. doi: 10.1007/s00198-011-1766-zVan der Weijden MA, van der Horst-Bruinsma IE, van Denderen JC, et al. High frequency of vertebral fractures in early spondylarthropathies. Osteoporos Int. 2012;23:1683-90. doi: 10.1007/s00198-011-1766-zRiesco M, Manzano F, Font P, et al. Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. Clin Rheumatol. 2013 Dec;32(12):1799-804. doi: 10.1007/s10067-013-2322-3Riesco M, Manzano F, Font P, et al. Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. Clin Rheumatol. 2013 Dec;32(12):1799-804. doi: 10.1007/s10067-013-2322-3Pedreira PG, Pinheiro MM, Szejnfeld VL. Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther. 2011 Feb 7;13(1):R16. doi: 10.1186/ar3240Pedreira PG, Pinheiro MM, Szejnfeld VL. Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther. 2011 Feb 7;13(1):R16. doi: 10.1186/ar3240Del Puente A, Esposito A, Costa L, et al. Fragility fractures in patients with psoriatic arthritis. J Rheumatol. 2015 Nov;93:36-9. doi: 10.3899/jrheum.150633Del Puente A, Esposito A, Costa L, et al. Fragility fractures in patients with psoriatic arthritis. J Rheumatol. 2015 Nov;93:36-9. doi: 10.3899/jrheum.150633Baskan B, Oten E, Sivas F, et al. The relationship between vitamin D, vertebral deformity and quality of life in psoriatic arthritis. Acta Reumatol Port. 2016 Oct-Dec;41(4):350-8.Baskan B, Oten E, Sivas F, et al. The relationship between vitamin D, vertebral deformity and quality of life in psoriatic arthritis. Acta Reumatol Port. 2016 Oct-Dec;41(4):350-8.Ogdie A, Harter L, Shin D, et al. The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study. Ann Rheum Dis. 2017 Jan 16. doi: 10.1136/annrheumdis-2016-210441Ogdie A, Harter L, Shin D, et al. The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study. Ann Rheum Dis. 2017 Jan 16. doi: 10.1136/annrheumdis-2016-210441Zhu TY, Griffith JF, Qin L, et al. Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors. Osteoporos Int. 2015 Jan;26(1):261-72. doi: 10.1007/s00198-014-2858-3Zhu TY, Griffith JF, Qin L, et al. Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors. Osteoporos Int. 2015 Jan;26(1):261-72. doi: 10.1007/s00198-014-2858-3Kocijan R, Englbrecht M, Haschka J, et al. Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients. J Bone Miner Res. 2015 Oct;30(10):1775-83. doi: 10.1002/jbmr.2521Kocijan R, Englbrecht M, Haschka J, et al. Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients. J Bone Miner Res. 2015 Oct;30(10):1775-83. doi: 10.1002/jbmr.2521Kocijan R, Finzel S, Englbrecht M, et al. Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity. Ann Rheum Dis. 2014 Nov;73(11):2022-8. doi: 10.1136/annrheumdis-2013-203791Kocijan R, Finzel S, Englbrecht M, et al. Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity. Ann Rheum Dis. 2014 Nov;73(11):2022-8. doi: 10.1136/annrheumdis-2013-203791Kawai VK, Grijalva CG, Arbogast PG, et al. Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care Res (Hoboken). 2013 Jul;65(7):1085-94. doi: 10.1002/acr.21937Kawai VK, Grijalva CG, Arbogast PG, et al. Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care Res (Hoboken). 2013 Jul;65(7):1085-94. doi: 10.1002/acr.21937Szentpetery A, McKenna MJ, Murray BF, et al. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis. J Rheumatol. 2013 May;40(5):653-62. doi: 10.3899/jrheum.120397Szentpetery A, McKenna MJ, Murray BF, et al. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis. J Rheumatol. 2013 May;40(5):653-62. doi: 10.3899/jrheum.120397Siu S, Haraoui B, Bissonnette R, et al. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Arthritis Care Res. 2015;67(6):754-64. doi: 10.1002/acr.22519Siu S, Haraoui B, Bissonnette R, et al. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Arthritis Care Res. 2015;67(6):754-64. doi: 10.1002/acr.22519Cranney AB, McKendry RJ, Wells GA, et al. The effect of low dose methotrexate on bone density. J Rheumatol. 2001 Nov; 28(11):2395-9.Cranney AB, McKendry RJ, Wells GA, et al. The effect of low dose methotrexate on bone density. J Rheumatol. 2001 Nov; 28(11):2395-9.Касимова СГ. Коррекция костно-метаболических нарушений у больных псориатическим артритом. Автореф. дисс. … канд. мед. наук. Москва; 2011 [Kasimova SG. Korrektsiya kostno-metabolicheskikh narushenii u bol'nykh psoriaticheskim artritom. Avtoref. diss. ... kand. med. nauk [Correction of bone metabolic disorders in patients with psoriatic arthritis. Authorуs abstract. diss. ... Cand. Med. Sci.]. Moscow; 2011].Касимова СГ. Коррекция костно-метаболических нарушений у больных псориатическим артритом. Автореф. дисс. … канд. мед. наук. Москва; 2011 [Kasimova SG. Korrektsiya kostno-metabolicheskikh narushenii u bol'nykh psoriaticheskim artritom. Avtoref. diss. ... kand. med. nauk [Correction of bone metabolic disorders in patients with psoriatic arthritis. Authorуs abstract. diss. ... Cand. Med. Sci.]. Moscow; 2011].Petho Z, Kulcsar-Jakab E, Kalina E, et al. Vitamin D status in men with psoriatic arthritis: a case-control study. Osteoporos Int. 2015 Jul;26(7):1965-70. doi: 10.1007/s00198-015-3069-2Petho Z, Kulcsar-Jakab E, Kalina E, et al. Vitamin D status in men with psoriatic arthritis: a case-control study. Osteoporos Int. 2015 Jul;26(7):1965-70. doi: 10.1007/s00198-015-3069-2Solak B, Dikicier BS, Celik HD, Erdem T. Bone mineral density, 25-OH vitamin D and inflammation in patients with psoriasis. Photodermatol Photoimmunol Photomed. 2016 May;32(3):153-60. doi: 10.1111/phpp.12239Solak B, Dikicier BS, Celik HD, Erdem T. Bone mineral density, 25-OH vitamin D and inflammation in patients with psoriasis. Photodermatol Photoimmunol Photomed. 2016 May;32(3):153-60. doi: 10.1111/phpp.12239Urruticoechea-Arana A, Martin-Martinez MA, Castaneda S, et al. Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study. Arthritis Res Ther. 2015 Aug 14;17:211. doi: 10.1186/s13075-015-0704-4Urruticoechea-Arana A, Martin-Martinez MA, Castaneda S, et al. Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study. Arthritis Res Ther. 2015 Aug 14;17:211. doi: 10.1186/s13075-015-0704-4

The authors declare that there are no conflicts of interest present.